Finnish study demonstrates connection between genetic background and treatment outcomes among patients taking blood thinners
Press release 8 June, 2021 Genetic information stored in biobanks brings new opportunities for individualised health care. According to a new study by VTT, tailoring based on genetic information can improve treatment outcomes of blood thinner treatment. There are nearly 400,000 users of blood thinners in Finland, and so the increased understanding of the effects of genetics on the drug therapy potentially benefits a large number of patients.Antithrombotic medicines that affect blood clotting reduce the formation of blockages in blood vessels. The PreMed study led by VTT examined the